98%
921
2 minutes
20
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1111/apt.18136 | DOI Listing |
J Interv Card Electrophysiol
September 2025
School of Medicine and Health, Department of Clinical Medicine-Clinical Department for Cardiology, University Medical Centre, Technical University of Munich, Munich, Germany.
JACC Asia
September 2025
Prince of Wales Hospital, the Chinese University of Hong Kong, Hong Kong SAR, China; Li Ka Shing Institute of Health Sciences, the Chinese University of Hong Kong, Hong Kong SAR, China. Electronic address:
JACC Asia
September 2025
Centro de Estudos Avançados em Educação e Formação Médica, Universidade Agostinho Neto, Luanda, Angola; Hospital Militar Principal/Instituto Superior, Luanda, Angola.
J Affect Disord
September 2025
Department of Psychosomatic Medicine, Shandong Mental Health Center, Jinan, Shandong, China. Electronic address:
Cancer Lett
September 2025
Faculty of Research, Chettinad Hospital and Research Institute, Chettinad Academy of Research and Education, Kelambakkam, 603103, Tamilnadu, India.
Recent findings by Yazdi et al. in Cancer Letters present a mechanistic breakthrough in understanding resistance to HER2-targeting antibody-drug conjugates (ADCs). Their identification of drug-persistent polyploid giant cancer cells (PGCCs) as active participants in resistance redefines our understanding of intratumoral plasticity and therapeutic evasion.
View Article and Find Full Text PDF